Earnings
RIGL
3.830
-11.03%
-0.475
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2019-12-31
59.29M
59.29M
906.00K
58.38M
74.59M
52.88M
--
--
--
128.38M
--
-69.09M
2.20M
0.00
--
2.20M
-66.89M
--
-66.89M
--
-66.89M
-66.89M
--
--
-0.40
FY 2018-12-31
44.51M
44.51M
287.00K
44.22M
70.00M
46.90M
--
--
--
117.19M
--
-72.68M
2.20M
0.00
--
2.20M
-70.48M
--
-70.48M
--
-70.48M
-70.48M
--
--
-0.44
FY 2017-12-31
4.48M
4.48M
--
--
37.83M
46.27M
--
--
--
84.10M
--
-79.62M
892.00K
732.00K
--
1.62M
-77.99M
0.00
-77.99M
--
-77.99M
-77.99M
0.00
--
-0.62
FY 2016-12-31
20.38M
20.38M
--
--
21.41M
63.45M
--
--
--
90.12M
--
-69.74M
437.00K
88.00K
--
525.00K
-69.22M
--
-69.22M
--
-69.22M
-69.22M
--
--
-0.73
FY 2015-12-31
28.89M
28.89M
--
--
17.81M
62.83M
--
--
--
80.64M
--
-51.74M
222.00K
57.00K
--
279.00K
-51.46M
--
-51.46M
--
-51.46M
-51.46M
--
--
-0.58

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out RIGL latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Rigel Pharms recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.